Related Experiment Video
Updated: Sep 27, 2026

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis
Kazuyuki Takata1, Yoshihisa Kitamura, Jun-ichi Kakimura
1Department of Neurobiology, Kyoto Pharmaceutical University, Japan.
Abstract:
In Alzheimer's disease (AD), fibrillar amyloid-beta (Abeta) peptides form senile plaques associated with activated microglia. Recent studies have indicated that microglial Abeta clearance is facilitated by several activators such as transforming growth factor-beta1 (TGF-beta1). The relationship between microglia and Abeta formation and deposition is still unclear. In the present study, high mobility group protein-1 (HMG1) inhibited the microglial uptake of Abeta (1-42) in the presence and absence of TGF-beta1. In addition, HMG1 bound to Abeta (1-42) and stabilized the oligomerization. In AD brains, protein levels of HMG1 were significantly increased in both the cytosolic and particulate fractions, and HMG1 and Abeta were colocalized in senile plaques associated with microglia. These results suggest that HMG1 may regulate the homeostasis of extracellular Abeta (1-42) and Abeta oligomerization.
Insights
High mobility group protein-1 (HMG1) hinders microglial clearance of amyloid-beta (Abeta) and stabilizes Abeta oligomers. Increased HMG1 in Alzheimer
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Alzheimer's disease (AD) is characterized by amyloid-beta (Abeta) plaques and activated microglia.
- Microglial Abeta clearance is crucial, with factors like transforming growth factor-beta1 (TGF-beta1) playing a role.
- The precise interaction between microglia and Abeta deposition in AD remains incompletely understood.
Purpose of the Study:
- To investigate the role of high mobility group protein-1 (HMG1) in microglial Abeta uptake and oligomerization.
- To determine the effect of HMG1 on Abeta (1-42) clearance in the presence and absence of TGF-beta1.
- To examine HMG1 expression and localization in Alzheimer's disease brains.
Main Methods:
- Assessing microglial uptake of Abeta (1-42) with and without HMG1 and TGF-beta1.
- Investigating HMG1 binding to Abeta (1-42) and its effect on oligomerization.
- Quantifying HMG1 protein levels in cytosolic and particulate fractions of AD brain tissue.
- Examining the colocalization of HMG1 and Abeta in senile plaques via immunohistochemistry.
Main Results:
- High mobility group protein-1 (HMG1) significantly inhibited microglial uptake of Abeta (1-42), irrespective of TGF-beta1 presence.
- HMG1 was found to bind to Abeta (1-42), promoting the stabilization of Abeta oligomers.
- Elevated HMG1 protein levels were observed in both cytosolic and particulate fractions of Alzheimer's disease brains.
- HMG1 and Abeta were found to be colocalized within senile plaques, often associated with microglia.
Conclusions:
- HMG1 plays a role in modulating extracellular Abeta (1-42) homeostasis.
- HMG1 appears to influence Abeta (1-42) oligomerization, potentially contributing to AD pathogenesis.
- The findings suggest HMG1 as a potential regulator of Abeta deposition and microglial response in Alzheimer's disease.
Related Concept Videos
Export of Misfolded Proteins out of the ER
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Lysosomal Hydrolases
Hyperglycemia
